347 related articles for article (PubMed ID: 26244293)
1. Topical TSG-6 Administration Protects the Ocular Surface in Two Mouse Models of Inflammation-Related Dry Eye.
Lee MJ; Kim DH; Ryu JS; Ko AY; Ko JH; Kim MK; Wee WR; Khwarg SI; Oh JY
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5175-81. PubMed ID: 26244293
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
[TBL] [Abstract][Full Text] [Related]
3. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
[TBL] [Abstract][Full Text] [Related]
4. FTY720 ameliorates Dry Eye Disease in NOD mice: Involvement of leukocytes inhibition and goblet cells regeneration in ocular surface tissue.
Xiao W; Xu GT; Zhang J; Zhang J; Zhang Y; Ye W
Exp Eye Res; 2015 Sep; 138():145-52. PubMed ID: 26187517
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye.
Qu M; Qi X; Wang Q; Wan L; Li J; Li W; Li Y; Zhou Q
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3776-3785. PubMed ID: 31503282
[TBL] [Abstract][Full Text] [Related]
7. The Link module of human TSG-6 (Link_TSG6) promotes wound healing, suppresses inflammation and improves glandular function in mouse models of Dry Eye Disease.
Oh JY; Ryu JS; Kim HJ; Kouvatsos N; Dodd RJ; Choi SH; Kim YJ; Milner CM; Day AJ
Ocul Surf; 2022 Apr; 24():40-50. PubMed ID: 34968766
[TBL] [Abstract][Full Text] [Related]
8. Effects of Quercetin in a Mouse Model of Experimental Dry Eye.
Oh HN; Kim CE; Lee JH; Yang JW
Cornea; 2015 Sep; 34(9):1130-6. PubMed ID: 26203745
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of topical adiponectin in a mouse model of desiccating stress-induced dry eye.
Li Z; Woo JM; Chung SW; Kwon MY; Choi JS; Oh HJ; Yoon KC
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):155-62. PubMed ID: 23211823
[TBL] [Abstract][Full Text] [Related]
10. Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis.
Chen W; Zhang X; Liu M; Zhang J; Ye Y; Lin Y; Luyckx J; Qu J
Exp Eye Res; 2009 Sep; 89(3):311-8. PubMed ID: 19345212
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of ocular surface TNF-α reduces ocular surface and lacrimal gland inflammation induced by in vivo dry eye.
Ji YW; Byun YJ; Choi W; Jeong E; Kim JS; Noh H; Kim ES; Song YJ; Park SK; Lee HK
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7557-66. PubMed ID: 24052636
[TBL] [Abstract][Full Text] [Related]
12. Topical Application of Mizoribine Suppresses CD4+ T-cell-Mediated Pathogenesis in Murine Dry Eye.
Zhang X; Lin X; Liu Z; Wu Y; Yang Y; Ouyang W; Li W; Liu Z
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6056-6064. PubMed ID: 29204644
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of uridine on cornea in a rabbit dry eye model.
Oh JY; In YS; Kim MK; Ko JH; Lee HJ; Shin KC; Lee SM; Wee WR; Lee JH; Park M
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1102-9. PubMed ID: 17325152
[TBL] [Abstract][Full Text] [Related]
14. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
[TBL] [Abstract][Full Text] [Related]
15. Effects of subconjunctival administration of anti-high mobility group box 1 on dry eye in a mouse model of Sjӧgren's syndrome.
Kim KH; Kim DH; Jeong HJ; Ryu JS; Kim YJ; Oh JY; Kim MK; Wee WR
PLoS One; 2017; 12(8):e0183678. PubMed ID: 28837629
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model.
Seo MJ; Kim JM; Lee MJ; Sohn YS; Kang KK; Yoo M
Curr Eye Res; 2010 Feb; 35(2):165-75. PubMed ID: 20136427
[TBL] [Abstract][Full Text] [Related]
17. Effect of 0.025% FK-506 eyedrops on botulinum toxin B-induced mouse dry eye.
Lin BW; Chen MZ; Fan SX; Chuck RS; Zhou SY
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):45-53. PubMed ID: 25491293
[TBL] [Abstract][Full Text] [Related]
18. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
[TBL] [Abstract][Full Text] [Related]
19. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
[TBL] [Abstract][Full Text] [Related]
20. 0.005% Preservative-Free Latanoprost Induces Dry Eye-Like Ocular Surface Damage via Promotion of Inflammation in Mice.
Yang Y; Huang C; Lin X; Wu Y; Ouyang W; Tang L; Ye S; Wang Y; Li W; Zhang X; Liu Z
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3375-3384. PubMed ID: 30025085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]